Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Heart Disease Health Center

Font Size

Coumadin Recalled Over Potency Concern

1.85 Million Coumadin Tablets Recalled in U.S.
WebMD Health News
Reviewed by Laura J. Martin, MD

May 3, 2011 -- Bristol-Myers Squibb has recalled 1.85 million 5-milligram Coumadin tablets in the U.S.

The recalled lot of Coumadin (number 9H49374A, expiration date Sept. 30, 2012) was sold to pharmacies in 1,000-tablet bottles and repackaged for individual prescriptions. Patients taking 5-milligram Coumadin tablets should contact their pharmacies to see if their prescription is included in the recall.

Patients should NOT stop taking their Coumadin. If their prescription is included in the recall, patients should contact their doctors for medical advice.

Coumadin is the best known brand name for warfarin, a drug that prevents blood clots. The recall affects only the Coumadin brand and not generic brands.

Testing of a single tablet from a returned bottle of Coumadin showed that it was more potent than it should have been.

Coumadin levels must be carefully adjusted for each patient. Coumadin that is more potent than expected could increase a patient's risk of dangerous bleeding. Coumadin that is less potent than expected could increase a patient's risk of blood clots, leading to stroke or heart attack. There have been no reported patient injuries during this recall.

The recalled lot of Coumadin includes 600,000 tablets sent to Ecuador and to Argentina.

Patients and health care professionals with questions about the recall may telephone Stericycle Inc. at 866-918-8739.

Today on WebMD

x-ray of human heart
A visual guide.
atrial fibrillation
Symptoms and causes.
heart rate graph
10 things to never do.
heart rate
Get the facts.
empty football helmet
red wine
eating blueberries
Simple Steps to Lower Cholesterol
Inside A Heart Attack
Omega 3 Sources
Salt Shockers
lowering blood pressure